Kenya Targets 50% Local Production of Essential Medicines

𝐍𝐚𝐢𝐫𝐨𝐛𝐢, 𝐉𝐮𝐧𝐞 23, 𝟐𝟎𝟐𝟓

The government has committed to increasing local manufacturing of essential medicines from the current 20% to 50%, according to Dr. Ouma Oluga, Principal Secretary for Medical Services.

Speaking during the Haleon Kenya Stakeholder Breakfast Session in Nairobi, Dr. Oluga noted that expanding local production will boost the availability and affordability of health commodities. He emphasized the government’s engagement with sector partners to support this shift, particularly in research, innovation, and pharmaceutical ingredient supply.

Dr. Oluga also highlighted the importance of a robust local industry in addressing national health priorities and commended Haleon for its leadership in the space. He announced plans for a new drug tracking system, developed in collaboration with the Global Standards Organization, to combat counterfeit medicines and ensure the safety of health products.

The event was attended by key stakeholders including Haleon’s leadership team and representatives from the UK’s Department for Business and Trade. Haleon, formerly GlaxoSmithKline, is a global player in consumer health products across six major categories